REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/26/2026
Back to search
Official data from USPTO
ACTICOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACTICOR
ST13
US500000079265913Class
1, 5, 42
Filing
79265913
Registration
6253399
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
01/27/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
07/05/2019
Registration date
01/26/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/26/2021
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
TMO LAW OFFICE 116
Holders and representatives
Holders
A. B. (pessoa física)
Representatives
Pina M. Campagna Carter, DeLuca, & Farrell, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Monoclonal antibodies for scientific use; reagents for scientific or medical research use; biochemicals for in vitro and in vivo scientific use and medical research use; biological preparations * of monoclonal antibodies * for use in industry and science ; proteins in raw material form for use in scientific research
Class 5
Antibodies in the form of biological preparations for the prevention and treatment of arterial and venous thrombosisrestenosisthromboembolic diseases; pharmaceuticals for prevention and treatment of arterial and venous thrombosisrestenosisthromboembolic diseases; pharmaceutical preparations and substances prevention and treatment of arterial and venous thrombosisrestenosisthromboembolic diseases
Class 42
Medical and scientific laboratory services relating to the production of antibodies; biotechnological and pharmaceutical drug development services; pharmaceutical and biotechnological research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields
Publications
History of USPTO decisions and trademark events.
36 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/28/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
04/28/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/26/2021
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
01/28/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
01/28/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
12/17/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
12/11/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/09/2020
PUBO
PUBLISHED FOR OPPOSITION
06/09/2020
GPNX
NOTIFICATION PROCESSED BY IB
06/05/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/20/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/20/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/20/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2020
ALIE
ASSIGNED TO LIE
05/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/27/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/27/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/27/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/27/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/27/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/07/2020
RFNT
REFUSAL PROCESSED BY IB
11/02/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/17/2019
RFRR
REFUSAL PROCESSED BY MPU
10/17/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/02/2019
CNRT
NON-FINAL ACTION WRITTEN
10/01/2019
DOCK
ASSIGNED TO EXAMINER
09/23/2019
MAFR
APPLICATION FILING RECEIPT MAILED
09/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/31/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/22/2019
Continuous trademark protection
Get notified about every new filing that threatens ACTICOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.